PDCD1 and neoplasm: We assessed combinatorial treatments in MC38 tumor bearing mice by choosing an injection dose of cells and treatment schedule where monotherapy with anti-CTLA-4, anti-PD-1, or neo VAX alone is largely ineffective (Figure 7B).